---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-031559"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T05:53:47.352550+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sangamo stockholders approve 14M share increase to 2018 equity plan

## Summary
- Share reserve increased by 14,000,000 shares; total now includes 8.8M, 9.9M, 7.9M, 10M, 11M from prior years.
- Incentive stock option limit raised to 123,200,000 shares.
- All nine director nominees elected, including Courtney Beers, Kenneth Hillan, and H. Stewart Parker.
- Advisory say-on-pay approved: 32.8M for, 23.2M against, 1.3M abstentions.
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 119.6M for.

## SEC filing metadata
- accession: 0001628280-25-031559
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/0001628280-25-031559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/sgmo-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-031559
- JSON: https://secwatch.observer/filing/0001628280-25-031559.json
- Plain text: https://secwatch.observer/filing/0001628280-25-031559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.